Metastatic Renal Cell Carcinoma Treated With Cabozantinib
1 clinical trials · Condition
◉ Watch Metastatic Renal Cell Carcinoma Treated With Cabozantinib
| Record | Firm | Date |
|---|---|---|
| Development of a Cabozantinib (Cabometyx) Symptom Management Application for Use in Patients With Renal Cancer (NCT03867045) | Duke University | 2019-08-21 |
Track Metastatic Renal Cell Carcinoma Treated With Cabozantinib automatically
Every clearance here is in the API, with alerts when new ones post.